Tae Park Sang
Directeur/Membre du Conseil chez Oxford Cancer Biomarkers Ltd.
Profil
Tae Park Sang is a Non-Executive Director at Oxford Cancer Biomarkers Ltd.
He was previously the Chief Executive Officer at Dx & Vx Co., Ltd.
Postes actifs de Tae Park Sang
| Sociétés | Poste | Début |
|---|---|---|
Oxford Cancer Biomarkers Ltd.
 Oxford Cancer Biomarkers Ltd. Hospital/Nursing ManagementHealth Services Oxford Cancer Biomarkers Ltd. provides cancer treatment services. It offers a suite of drug-specific companion diagnostic kits that allow the biomarker to be directly measured in tumor biopsies or patient DNA and thereby patients that respond favorably to the drug identified. The company was founded by David Kerr and Nick LaThangue in 2012 and is headquartered in Oxford, the United Kingdom. | Directeur/Membre du Conseil | - |
Anciens postes connus de Tae Park Sang
| Sociétés | Poste | Fin |
|---|---|---|
| DX & VX CO., LTD. | Directeur Général | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DX & VX CO., LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Oxford Cancer Biomarkers Ltd.
Oxford Cancer Biomarkers Ltd. Hospital/Nursing ManagementHealth Services Oxford Cancer Biomarkers Ltd. provides cancer treatment services. It offers a suite of drug-specific companion diagnostic kits that allow the biomarker to be directly measured in tumor biopsies or patient DNA and thereby patients that respond favorably to the drug identified. The company was founded by David Kerr and Nick LaThangue in 2012 and is headquartered in Oxford, the United Kingdom. | Health Services |
